相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of new potent hits against intracellular Trypanosoma cruzi by QSAR-based virtual screening
Cleber C. Melo-Filho et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Trypanosoma cruzi-specific IFN-γ-producing cells in chronic Chagas disease associate with a functional IL-7/IL-7R axis (vol 12, e0006998, 2018)
Maria A. Natale et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Chagas Cardiomyopathy in Latin America Review
Jefferson Luis Vieira et al.
CURRENT CARDIOLOGY REPORTS (2019)
N-Nitrosulfonamides as Carbonic Anhydrase Inhibitors: A Promising Chemotype for Targeting Chagas Disease and Leishmaniasis
Alessandro Bonardi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Drug Discovery for Kinetoplastid Diseases: Future Directions
Srinivasa P. S. Rao et al.
ACS INFECTIOUS DISEASES (2019)
Phenotypic screening approaches for Chagas disease drug discovery
Eric Chatelain et al.
EXPERT OPINION ON DRUG DISCOVERY (2018)
Leishmania and other intracellular pathogens: selectivity, drug distribution and PK-PD [BSP Autumn Symposium Microbial protein targets: towards understanding and intervention, 14th-16th September 2016, University of Durham UK]
Simon L. Croft
PARASITOLOGY (2018)
Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity
Bianca Zingales
ACTA TROPICA (2018)
From Medicinal Chemistry to Human Health: Current Approaches to Drug Discovery for Cancer and Neglected Tropical Diseases
Leonardo G. Ferreira et al.
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2018)
Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma cruzi Strain in Mice
Livia de Figueiredo Diniz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Current advances in drug discovery for Chagas disease
Caue Benito Scarim et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial
Faustino Torrico et al.
LANCET INFECTIOUS DISEASES (2018)
A novel nanoluciferase-based system to monitor Trypanosoma cruzi infection in mice by bioluminescence imaging
Erica Silberstein et al.
PLOS ONE (2018)
Response to different benznidazole doses in animal models of chronic phase Chagas disease: a critical review
Caue Benito Scarim et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2018)
A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients
Maan Zrein et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
The rise of neglected tropical diseases in the new Texas
Peter J. Hotez
PLOS NEGLECTED TROPICAL DISEASES (2018)
Electrocardiographic abnormalities in Chagas disease in the general population: A systematic review and meta-analysis
Lyda Z. Rojas et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery
Lorna M. MacLean et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure
Fernando J. Sanchez-Valdez et al.
ELIFE (2018)
Innovation in neglected tropical disease drug discovery and development
Hong-Bo Weng et al.
INFECTIOUS DISEASES OF POVERTY (2018)
In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus
Raimunda S. S. Azevedo et al.
SCIENTIFIC REPORTS (2018)
Is the priority review voucher program stimulating new drug development for tropical diseases?
Kirk W. Kerr et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Update on drug development targeting parasite cysteine proteases
James H. McKerrow
PLOS NEGLECTED TROPICAL DISEASES (2018)
Alleviating the Neglected Tropical Diseases: Recent Developments in Diagnostics and Detection
Satakshi Hazra et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)
Advances on Aptamers against Protozoan Parasites
Juan David Ospina-Villa et al.
GENES (2018)
Chagas disease: An underrecognized diagnosis
Dan M. Tzizik et al.
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS (2018)
Advances in structure-based drug discovery of carbonic anhydrase inhibitors
Claudiu T. Supuran
EXPERT OPINION ON DRUG DISCOVERY (2017)
Nanoemulsions of sulfonamide carbonic anhydrase inhibitors strongly inhibit the growth of Trypanosoma cruzi
Alane Beatriz Vermelho et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers The STOP-CHAGAS Trial
Carlos A. Morillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Recently differentiated epimastigotes from Trypanosoma cruzi are infective to the mammalian host
Rafael Luis Kessler et al.
MOLECULAR MICROBIOLOGY (2017)
Chagas disease: review of needs, neglect, and obstacles to treatment access in Latin America
Eloan Pinheiro et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2017)
Chagas disease research and development: Is there light at the end of the tunnel?
Eric Chatelain
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2017)
Experimental and Clinical Treatment of Chagas Disease: A Review
Policarpo Ademar Sales Junior et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery
Sandra Duffy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Carbonic anhydrases from Trypanosoma and Leishmania as anti-protozoan drug targets
Alane B. Vermelho et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Current drug therapy and pharmaceutical challenges for Chagas disease
Jose Bermudez et al.
ACTA TROPICA (2016)
Progress Report on Neglected Tropical Disease Drug Donation Programs
Joshua P. Cohen et al.
CLINICAL THERAPEUTICS (2016)
Inhibition of carbonic anhydrase from Trypanosoma cruzi for the management of Chagas disease: an underexplored therapeutic opportunity
Claudiu T. Supuran
FUTURE MEDICINAL CHEMISTRY (2016)
An alternative and innovative Research and Development model to ensure access to medicines Neglected diseases, neglected populations, and biomedical innovation system
Bernard Pecoul
M S-MEDECINE SCIENCES (2016)
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
Shilpi Khare et al.
NATURE (2016)
Autochthonous Transmission of Trypanosoma Cruzi in Southern California
Salvador Hernandez et al.
Open Forum Infectious Diseases (2016)
Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly Sensitive In Vivo Imaging
Amanda Fortes Francisco et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
The use of posaconazole against Chagas disease
Israel Molina et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2015)
Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives
Maria-Jesus Pinazo et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2015)
A novel ABCG-like transporter of Trypanosoma cruzi is involved in natural resistance to benznidazole
Bianca Zingales et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2015)
Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy
C. A. Morillo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3high regulatory T cells in humans
Makoto Miyara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Translational challenges of animal models in Chagas disease drug development: a review
Eric Chatelain et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open Resource
Imanol Pena et al.
SCIENTIFIC REPORTS (2015)
Aptamer-Based Detection of Disease Biomarkers in Mouse Models for Chagas Drug Discovery
Fernanda Fortes de Araujo et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
A New Experimental Model for Assessing Drug Efficacy against Trypanosoma cruzi Infection Based on Highly Sensitive In Vivo Imaging
Michael D. Lewis et al.
JOURNAL OF BIOMOLECULAR SCREENING (2015)
Chagas Disease Drug Discovery: Toward a New Era
Eric Chatelain
JOURNAL OF BIOMOLECULAR SCREENING (2015)
A Clinical Adverse Drug Reaction Prediction Model for Patients with Chagas Disease Treated with Benznidazole
Gilberto Marcelo Sperandio da Silva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Antitrypanosomal Activity of Fexinidazole Metabolites, Potential New Drug Candidates for Chagas Disease
Maria T. Bahia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Serum biomarkers predictive of cure in Chagas disease patients after nifurtimox treatment
Cynthia Santamaria et al.
BMC INFECTIOUS DISEASES (2014)
New, Combined, and Reduced Dosing Treatment Protocols Cure Trypanosoma cruzi Infection in Mice
Juan M. Bustamante et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
QSAR Modeling: Where Have You Been? Where Are You Going To?
Artem Cherkasov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity
Bianca Zingales et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2014)
The ChEMBL bioactivity database: an update
A. Patricia Bento et al.
NUCLEIC ACIDS RESEARCH (2014)
A Genome-Wide Analysis of Genetic Diversity in Trypanosoma cruzi Intergenic Regions
Leonardo G. Panunzi et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
High Throughput Screening for Anti-Trypanosoma cruzi Drug Discovery
Julio Alonso-Padilla et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Aptamer Based, Non-PCR, Non-Serological Detection of Chagas Disease Biomarkers in Trypanosoma cruzi Infected Mice
Rana Nagarkatti et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
In Vitro and In Vivo Studies of the Antiparasitic Activity of Sterol 14α-Demethylase (CYP51) Inhibitor VNI against Drug-Resistant Strains of Trypanosoma cruzi
Maria de Nazare Correia Soeiro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Anion inhibition studies of the α-carbonic anhydrase from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease
Peiwen Pan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review
Ana Requena-Mendez et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Cloning, Characterization, and Sulfonamide and Thiol Inhibition Studies of an α-Carbonic Anhydrase from Trypanosoma cruzi, the Causative Agent of Chagas Disease
Peiwen Pan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Drug rechallenge and treatment beyond progression-implications for drug resistance
Elizabeth A. Kuczynski et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Electrocardiographic Abnormalities in Trypanosoma cruzi Seropositive and Seronegative Former Blood Donors
Antonio L. Ribeiro et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
The revised Trypanosoma cruzi subspecific nomenclature: Rationale, epidemiological relevance and research applications
Bianca Zingales et al.
INFECTION GENETICS AND EVOLUTION (2012)
Organ tropism during the acute and chronic phases of Trypanosoma cruzi infection in BALB/c mice
L. R. C. Oliveira et al.
JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES (2012)
Transgenic parasites accelerate drug discovery
Ana Rodriguez et al.
TRENDS IN PARASITOLOGY (2012)
Fexinidazole: A Potential New Drug Candidate for Chagas Disease
Maria Terezinha Bahia et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Sensitive and Specific Detection of Trypanosoma cruzi DNA in Clinical Specimens Using a Multi-Target Real-Time PCR Approach
Yvonne Qvarnstrom et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Interfering with pH regulation in tumours as a therapeutic strategy
Dario Neri et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
International Study to Evaluate PCR Methods for Detection of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients
Alejandro G. Schijman et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Image-Based High-Throughput Drug Screening Targeting the Intracellular Stage of Trypanosoma cruzi, the Agent of Chagas' Disease
Juan C. Engel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina
Sergio Sosa-Estani et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2009)
Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies?
Yara M. Gomes et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2009)
Two approaches to discovering and developing new drugs for Chagas disease
J. H. McKerrow et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2009)
A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI
B. Zingales et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2009)
A new genotype of Trypanosoma cruzi associated with bats evidenced by phylogenetic analyses using SSU rDNA, cytochrome b and Histone H2B genes and genotyping based on ITS1 rDNA
A. Marcili et al.
PARASITOLOGY (2009)
ACCIDENTAL INFECTION BY Trypanosoma cruzi FOLLOW-UP BY THE POLYMERASE CHAIN REACTION: CASE REPORT
Andrea Tieko Kinoshita-Yanaga et al.
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO (2009)
Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity
Claudiu T. Supuran et al.
EXPERT OPINION ON EMERGING DRUGS (2008)
Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host
Juan Diego Maya et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY (2007)
Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations
S Garcia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Frequency of interferon-γ-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease
SA Laucella et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Drug development for neglected diseases: a deficient market and a public-health policy failure
P Trouiller et al.
LANCET (2002)
Identification of six Trypanosoma cruzi phylogenetic lineages by random amplified polymorphic DNA and multilocus enzyme electrophoresis
S Brisse et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2000)
分享论文
